Roche announced today that it will increase production of its anti-flu vaccine Tamiflu to 300 million units per year by 2007, up tenfold from 2004 when Roche first decided to step up manufacturing of the drug. With countries stockpiling the Tamiflu in the event of a pandemic, Roche has been under pressure to license out production of the vaccine and has already been approached by 150 drug makers interested in acquiring the license.
- read this AP report